Literature DB >> 9002026

Predicting length of stay after hip or knee replacement for rheumatoid arthritis.

A Escalante1, T D Beardmore.   

Abstract

OBJECTIVE: To identify predictors of the postoperative length of stay (LOS) after hip or knee replacement for rheumatoid arthritis (RA).
METHODS: Demographic and clinical characteristics, medications, and postoperative course were abstracted from medical records of patients with RA who underwent total arthroplasties of the knee (TKA) or hip (THA) at our institution between 1987 and 1991. The relationship between these variables and the postoperative LOS was examined using life tables, linear regression, and multiple regression analyses.
RESULTS: During the 5 years of the study, 137 patients with RA underwent 119 TKA and 105 THA. The average LOS was 16.9 +/- 8.7 days after THA and 19.5 +/- 11.4 days after TKA (p = 0.08). Significantly longer LOS was associated with age > or = 55 years, female sex, non-white ethnicity, poor functional status, known positive rheumatoid factor, use of bone cement, and operating room (OR) time longer than 6 hours. In a multivariate regression model, a preoperative Steinbrocker functional class 3 or 4 was associated with an increase in LOS of 3.98 days (95% confidence interval 0.78, 7.18) and 7.14 days (2.59, 11.69), respectively, while a known positive rheumatoid factor predicted an increase in LOS of 2.76 days (0.17, 5.35). Among operative factors, the use of bone cement was associated with a LOS that was longer by 3.50 days (0.80, 6.20), and each hour increase in OR time with a delay in discharge of 1.75 days (1.18, 2.33). Major postoperative wound complications increased LOS by 16.46 days (11.40, 21.52).
CONCLUSION: Preoperative functional status is an important determinant of the rate of recovery of functional independence after surgery. Strategies for decreasing LOS after hip or knee replacements include optimization of preoperative functional status, early surgical intervention, and prevention of wound complications.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9002026

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

1.  When can I go home after my knee replacement? Factors affecting the duration of in-hospital stay after knee replacement.

Authors:  Vishesh Khanna; A V Gurava Reddy; Deepesh Daultani; Sukesh Rao Sankineani; Jai Khanna; Adarsh Annapareddy; Krishna Kiran Eachampati
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-07-04

2.  Rheumatoid arthritis vs osteoarthritis in patients receiving total knee arthroplasty: perioperative outcomes.

Authors:  Ottokar Stundner; Thomas Danninger; Ya-Lin Chiu; Xuming Sun; Susan M Goodman; Linda A Russell; Mark Figgie; Madhu Mazumdar; Stavros G Memtsoudis
Journal:  J Arthroplasty       Date:  2013-06-12       Impact factor: 4.757

3.  Early post-operative oxford knee score and knee society score predict patient satisfaction 2 years after total knee arthroplasty.

Authors:  Graham S Goh; Hamid Rahmatullah Bin Abd Razak; Darren Keng-Jin Tay; Ngai-Nung Lo; Seng-Jin Yeo
Journal:  Arch Orthop Trauma Surg       Date:  2020-10-12       Impact factor: 3.067

4.  Thirty-day complications in rheumatoid patients following total knee arthroplasty.

Authors:  Julio J Jauregui; Bhaveen H Kapadia; Anant Dixit; Qais Naziri; David J Hip-Flores; Steven F Harwin; Michael A Mont
Journal:  Clin Rheumatol       Date:  2015-08-04       Impact factor: 2.980

5.  The effect of a 12 week prehabilitation program on pain and function for patients undergoing total knee arthroplasty: A prospective controlled study.

Authors:  Ebru Aytekin; Erhan Sukur; Nuran Oz; Atakan Telatar; Saliha Eroglu Demir; Nil Sayiner Caglar; Yusuf Ozturkmen; Levent Ozgonenel
Journal:  J Clin Orthop Trauma       Date:  2018-04-17

6.  Predicting length of stay from an electronic patient record system: a primary total knee replacement example.

Authors:  Evelene M Carter; Henry W W Potts
Journal:  BMC Med Inform Decis Mak       Date:  2014-04-04       Impact factor: 2.796

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.